Editor’s EmulsionPSM INDIA Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSM Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
![Pooja Khaitan](https://jagograhakjago.com/PSMNewz/1Jul19/images/editor.jpg)
Warm Greetings!
We have been constantly putting our effort in reaching to our readers important news related to health, pharma and medicines through our newsletter. I take this opportunity in thanking all our subscribers who have contributed in making us better through their valuable feedback and suggestions.
In today’s issue, PSM India capsules captures Modi government’s past work as well as what could be the next approach by the government on Indian Pharma industries. Also learn how Cannabidiol has been researched as a powerful new antibiotic.
Read More>>>
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
DOSE OF THE DAY
Drug abuse impacts society negatively. It fuels terrorist activities & abets crime. On International Day Against Drug Abuse And Illicit Trafficking let's campaign against ill effects of narcotics & drug use and prevent millions of people from ruining their lives.
Dr Harsh Vardhan,
Union Minister for Health & Family Welfare,
Science & Technology, Earth Sciences, Govt of India
PSM India Capsules
What Modi 2.0 could mean for the Indian pharma industry?
The Rs 1,20,000 crore plus Indian pharma industry has been through a churn in the past five years. Over the last year, it has finally seen double-digit growth, after having suffered periods of single-digit growth and even de-growth, post demonetisation and implementation of the Goods and Services Tax (GST). It is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.
Study finds Cannabidiol a powerful new antibiotic
New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin. The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Drug Laws & Policy Injections
Price of 1032 medicines capped by governmentNew Delhi, Jun 21, 2019: The price of 1032 essential medicines have been capped by the government to help provide poor medicines at cheaper rates, the Rajya Sabha was informed Friday.
Aurobindo Pharma gets warning letter from USFDA for Andhra Pradesh unit Jun 21, 2019: Drug firm Aurobindo PharmaNSE -0.38 % Friday said it has received a warning letter from the US health regulator for one of its units in Srikakulam district, Andhra Pradesh, which was the subject of an inspection earlier this year.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_brwn.jpg)
Maharashtra FDA witnesses surge in new product approvals after initial hiccups following CDSCO mandated stability dataMumbai, June 25, 2019: Following Central Drugs Standard Control Organisation (CDSCO)’s mandate for submission of real time stability study on a drug for its initial three batches, the Maharashtra Food and Drug Administration (FDA) this year has witnessed a surge in new product approvals after a lean phase of almost a year.
Proposal for provisioning ayurvedic drugs sale license in Drugs Act again goes for review to Maharashtra govtMumbai, June 25, 2019: In order to effectively control spurious drugs sale in the state, the Maharashtra government is again reviewing the Maharashtra Food and Drug Administration (FDA)’s proposal third time for provisioning of ayurvedic drugs sale license in the Drugs and Cosmetics (D&C) Act.
NCLT approves Dhanuka Laboratories' resolution plan for Orchid PharmaChennai June 25, 2019: The National Company Law Tribunal (NCLT), Chennai Bench, has approved the resolution plan of Dhanuka Laboratories for debt-ridden Orchid Pharma. The tribunal rejected the application filed by Accord Life Spec, another resolution applicant.
FDA serves show-cause notice on drug traderNagpur, Jun 25, 2019: More troubles seem to be brewing for city-based pharmaceutical distributor Jeetendra Belani to whom state Food and Drug Administration (FDA) has sent a show-cause notice on Monday.
Pharma Injections
Lupin revamps quality governance; showcases Nagpur unit as face of things to comeJune 24, 2019: The risks associated with any slippage in maintaining high quality while manufacturing medicines can be too high. Leading Indian pharmaceutical companies who eschew the thought of being labelled makers of poor quality copycat drugs should be knowing this only too well by now.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
India seeks "clear roadmap" from China to ramp up export of pharma productsJune 21, 2019: In an unusual move, India on Friday used a hugely popular Chinese movie to seek enhanced market access for Indian medicines in China as the drug regulators of both countries held their first-ever meeting in Shanghai and brainstormed on removing the road blocks.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
IPA's ‘Vision 2030’ report stresses on 7 strategic interventions by govt to take Indian pharma industry to US$ 120-130 billion by 2030 Mumbai, June 24, 2019: The Indian Pharmaceutical Alliance (IPA)'s recent report on ‘Vision 2030’, which provides a roadmmap for the Indian pharmaceutical industry to grow from US$ 38 billion to US$ 120-130 billion by 2030, states that the government can be a key enabler to achieve this aspiration through seven strategic interventions. IPA represents 23 research based national pharmaceutical companies.
Proposal for provisioning ayurvedic drugs sale license in Drugs Act again goes for review to Maharashtra govt Mumbai, June 25, 2019: In order to effectively control spurious drugs sale in the state, the Maharashtra government is again reviewing the Maharashtra Food and Drug Administration (FDA)’s proposal third time for provisioning of ayurvedic drugs sale license in the Drugs and Cosmetics (D&C) Act.
Karnataka Homoeopathic Medical Association urges govt to open dedicated homoeo wings in all govt hospitals Bengaluru, June 25, 2019: The Karnataka Homoeopathic Medical Association has urged the government to open dedicated homoeopathic wings in all government hospitals in the state. It has also pressed the government to increase the number of homoeo dispensaries across 30 districts.
Indian Immunologicals to invest Rs. 75 crore to expand Karkapatla plant in Telangana Mumbai, June 24, 2019: Indian Immunologicals Ltd (IIL), a leading biologicals company, announced the ground-breaking of a new sterile filling facility (SFF) at its manufacturing plant in phase III of Genome Valley, Karkapatla, Ranga Reddy District, Telangana. With this investment of Rs. 75 crore in the upcoming filling facility, Indian Immunologicals Limited expects to increase its capacity to supply lifesaving vaccines such as the anti rabies vaccine (ARV) Abhayrab.
Drug Dopes
Bulk drugs park project at MIHAN, Nagpur still waiting for environmental clearanceMumbai, June 24, 2019: The proposed bulk drugs park project at the Multi-modal International Passenger and Cargo Hub Airport (MIHAN) in Nagpur has hit a major road block as it is yet to get the environmental clearance even after more than a year of designating the park as special economic zone (SEZ) for the purpose.
DoP directs NPPA to refix ceiling price of tiotropium inhalationMumbai, June 26, 2019: The Department of Pharmaceuticals (DoP) has directed the NPPA to refix the ceiling price of tiotropium inhalation (MDI) 9mcg/dose by considering the PTR of Tiomist 9mcg MDI being manufactured and marketed by Cadila Healthcare for the month of August, 2015, in addition to the data of other MDI manufacturing companies.
Supply of medicines, surgical equipment resume at KGMCH KOZHIKODE, Jun 25, 2019: The suppliers and distributors in Kozhikode on Tuesday decided to resume the supply of stents, medicines, surgical equipment and generic medicines to the fair price medical shop 'Karunya Pharmacy' at the Kozhikode Government Medical College hospital (KGMCH) and Hospital Development Society on the basis of a meeting held with district collector Sambasiva Rao.
Muzaffarpur: Advanced test machines installed at SKMCH MUZAFFARPUR, June 26, 2019: Government has taken an initiative for the betterment of government-led Sri Krishna Medical College and Hospital (SKMCH) hospital by installing portable digital X-ray machines and other advanced test machines, said Superintendent Sunil Kumar Shahi on Tuesday.
Meerut : X-ray conducted on dead man, explanation sought from 11 docs Meerut, June 26, 2019: In a shocking development and serious procedural lapse, an X-ray was conducted on a dead man at Lala Lajpat Rai Memorial Medical (LLRM) College in Meerut. The incident took place on June 20, when one Akhtar, a 45-year-old rickshaw puller, was brought to the medical college with injuries after he was hit by a car in Jagriti Vihar area. It is alleged that the doctors on the case prescribed an X-ray even though he was already dead by then.
Kerala is India’s healthiest state; UP, Odisha worst: Niti AayogNEW DELHI, June 26, 2019: Kerala remains at the top of the heap among larger states in terms of various health parameters, followed by Andhra Pradesh and Maharashtra. Uttar Pradesh, Odisha and Bihar are the worst performers, according to Niti Aayog’s latest health index released on Tuesday. Haryana, Rajasthan and Jharkhand top the charts based on incremental performance.
National Injections
Install panic buttons in hospitals, demands Dr Mahatme in RS NAGPUR, June 26, 2019: Senior ophthalmologist and Rajya Sabha member from Nagpur Dr Vikas Mahatme has demanded fast track courts for trial in cases of attacks on doctors. He also demanded panic buttons should be installed in hospitals to alert authorities about any such incident immediately.
Wait for critical dept at govt hospitals continuesVISAKHAPATNAM, 24 June 2019: The biggest tertiary care teaching hospital in north-coastal AP, Andhra Medical College (AMC) and King George Hospital (KGH) lack a government-sanctioned exclusive emergency medicine department (EMD) plus critical care department, as well as a transfusion medicine department.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
No tribal pharmacist is working in health dept of Jharkhand as all 30% reservation posts lying vacant Chennai, June 26, 2019: Even though the government of Jharkhand is getting sufficient funds from central government for uplifting health education, especially for medical and life-sciences, it is alleged that the government of this tribal state is not putting enough emphasize on pharmacy education to bring up the tribals into pharma profession. ![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
Karnataka govt invites Hamdard to enter into PPP model to set up dedicated Wellness centres in district hospitals Bengaluru, June 26, 2019: The Karnataka government has invited Hamdard India to set up its Wellness Centres in all the district hospitals in the state to give a boost to Unani system of medicine which Hamdard researches, manufactures and exports. ![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
BDCA to protest against alleged harassment by drug inspectors in the name of compliance Mumbai, June 26, 2019: The Bhagalpur District Chemists Association (BDCA) in Bihar has upped its ante for the alleged harassment by Bihar Directorate of Drugs Control inspectors in the name of drug laws compliance. They have announced that retailers will not buy any medicine from any of the pharma companies on July 20, 2019 which will be subsequently followed by wholesalers on August 16, 2019 as a mark of protest. ![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
Health department yet to find out who dumped live medicines TIRUPUR, June 25, 2019: The district health services department is still groping in the dark on identifying people who dumped hundreds of live medicines in a graveyard near Dharapuram in the district on June 17. ![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_grn.jpg)
Global Injections
Exposure to Anticholinergics May Increase Dementia RiskTUESDAY, June 25, 2019: Exposure to anticholinergic drugs is associated with an increased dementia risk, according to a study published online June 24 in JAMA Internal Medicine. Carol A.C. Coupland, Ph.D., from the University of Nottingham in the United Kingdom..
WHO introduces new tool ‘AWaRe’ and sets target to speed-up action against antimicrobial resistance Geneva, June 25, 2019: The World Health Organization (WHO) recently launched a global campaign urging governments to adopt a tool to reduce the spread of antimicrobial resistance, adverse events and costs.
US FDA accepts and grants priority review status to GSK’s sNDA for Zejula in late stage ovarian cancer
London, UK, June 25, 2019: GlaxoSmithKline plc announced that Tesaro, an oncology-focused business acquired by GSK, submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for Zejula (niraparib). The application was granted priority review and has an action date of 24 October 2019.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_brwn.jpg)
Prolonged transmission of a resistant bacterial strain in a Northern California hospital
June 23, 2019: Researchers have used whole genome sequencing (WGS) to demonstrate transmission of a single bacterial strain that possessed a carbapenem-resistance gene in a northern California hospital. The gene armed the bacteria with resistance to carbapenems, a type of antimicrobial drug reserved as a last-line treatment for serious infections. The research is presented on Sunday, June 23rd at ASM Microbe, the annual meeting of the American Society for Microbiology.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_brwn.jpg)
Voxelotor improves hemoglobin levels in sickle cell disease
JUNE 25, 2019: (HealthDay)—For individuals with sickle cell disease, 1,500 mg of voxelotor increases hemoglobin levels and reduces the incidence of worsening anemia compared with placebo, according to a study published in the June 14 issue of the New England Journal of Medicine.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_brwn.jpg)
Fake drugs that could kill are on the rise in Western countries
JUNE 25, 2019: Fake medicines—illegal and substandard pharmaceuticals—have until now largely been a problem in low and middle-income countries. Ranging from lifestyle products to lifesaving medicines, such products are now also on the rise in the Western world. The spread is concerning, as fake medicines can be completely ineffective or extremely toxic.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_brwn.jpg)
PSM PILL
“Canada Cannot Act As A Drugstore For The United States,” Says Academic
June 19, 2019: This editorial by Dr. Kristina Acri was published by the Fraser Institute on June 13, 2019. Acri is an associate professor of economics and chair of the Department of Economics & Business at Colorado College. According to a Trudeau government advisory council, which released its report Wednesday, Canada should construct a national pharmacare program. The report claims national pharmacare will improve drug coverage for Canadians and save money. But in reality, based on the experience of other countries, national pharamacare can put patients, innovation and innovative industries at risk.
Florida Man Convicted For Manufacturing And Selling Hundreds Of Thousands Of Counterfeit Oxycodone
June 18, 2019: On June 7, 2019, a federal jury found Dion Gregory Fisher, 33, of Seminole, FL, guilty of conspiring to manufacture and distribute fentanyl and fentanyl analogue, guilty of five counts of fentanyl distribution and manufacturing and eight counts of committing money laundering transactions involving more than $10,000 of narcotics proceeds, reports the Tampa Bay Reporter.
Frequently Asked Questions
Q1. What are the side effects of drugs?
Ans: Every drug has side effects. How vulnerable you are to these side effects depends on many different factors, which can be generally grouped as patient-related, drug-related, and environmentally or socially-related. Find out if you have any characteristics that will increase your susceptibility to drug-related reactions, and what you can do to manage some of these possible side effects. Read More>>>
SUBSCRIBER'S SYMPTOM
Healthy lifestyle can treat psoriasis
Article contributed by Nitesh Kothari, Madhya Pradesh
HYDERABAD: Experts stressed the need for timely diagnosis and a healthy lifestyle to treat psoriasis at an event on Tuesday. Psoriasis is an auto-immune skin condition that affects the skin, nails, joints and other parts of the body. Key signs of the condition include dry, itchy, flaky skin with red patches.![Read More](https://jagograhakjago.com/PSMNewz/17Jul14/images/readmore_brwn.jpg)
Blog Addicts
Mr. Deepak Narang, Medical Student PSM India is doing great job by spreading awareness among the people through its newsletter. Awesome Job!!!
Dr. Mridul Shukla, MD PediatricI am regular reader of PSM India newsletter The Prescription and it gives me all Pharma & medical related current news in one place. Great Work PSM India!!!
Mrs. Shakha Matoo, Pharma Professional
One Stop Shop for all Pharma related current news. Appreciate the effort by the Editor!!!
This Newsletter is brought to you by
![](https://jagograhakjago.com/PSMNewz/17Jul14/images/logo_janaushadhi.png)
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSM India may not be held responsible for any article published in The Prescription.